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Abstract  19 
In recent years, (re-)emerging arboviruses including Chikungunya virus (CHIKV) and Mayaro 20 
virus (MAYV) have caused growing concern due to expansion of insect vector ranges. No 21 
protective vaccine or specific antiviral strategies are currently available. Long-term morbidity 22 
after CHIKV infection includes debilitating chronic joint pain, which has associated health and 23 
economic impact. Here, we analyzed the early cell-intrinsic response to CHIKV and MAYV 24 
infection in primary human synovial fibroblasts. This interferon-competent cell type represents 25 
a potential source of polyarthralgia induced by CHIKV infection. Synovial fibroblasts from 26 
healthy and osteoarthritic donors were similarly permissive to CHIKV and MAYV infection ex 27 
vivo. Using RNA-seq, we defined a CHIKV infection-induced transcriptional profile with 28 
several hundred interferon-stimulated and arthralgia-mediating genes upregulated. Type I 29 
interferon was both secreted by infected fibroblasts and protective when administered 30 
exogenously. IL-6 secretion, which mediates chronic synovitis, however, was not boosted by 31 
infection. Single-cell RNA-seq and flow cytometric analyses uncovered an inverse correlation 32 
of activation of innate immunity and productive infection at the level of individual cells. In 33 
summary, primary human synovial fibroblasts serve as bona-fide ex vivo primary cell model of 34 
CHIKV infection and provide a valuable platform for studies of joint tissue-associated aspects 35 
of CHIKV immunopathogenesis. 36 
Keywords: chikungunya, fibroblasts, innate immunity, single-cell RNA-seq, transcriptomics 37 
.CC-BY-ND 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 
The copyright holder for this preprintthis version posted June 11, 2021. ; https://doi.org/10.1101/2020.06.07.138610doi: bioRxiv preprint 
3 
 
Introduction  38 
Chikungunya virus (CHIKV) and Mayaro virus (MAYV) are arthritogenic alphaviruses of the 39 
Togaviridae family, which are transmitted by Aedes sp. mosquitoes and circulate both in urban 40 
cycles between vectors and humans, and in sylvatic cycles [1-3]. Beyond the typically short 41 
acute phase associated with febrile illness and rashes, excruciating pain in multiple joints 42 
represents the most severe consequence of a CHIKV or MAYV infection in humans. The 43 
arthritis-like pain often manifests itself during the acute phase of the infection, but can persist 44 
in a subgroup of patients for months to years [4-6]. Symptoms cause a severe loss of quality of 45 
life and high economic costs, which is a burden especially for low-income countries [7]. The 46 
underlying pathophysiology of the chronic symptoms remains largely unclear, but appears to 47 
associate with circulating IL-6 [8] and IL-12 [9]. Furthermore, it may involve persisting viral 48 
RNA [9,10], although this scenario has been debated [11].  49 
Multiple studies on alphaviruses in immortalized model cell lines and in vivo in 50 
immunodeficient mice have provided valuable information on key aspects of CHIKV and 51 
MAYV tropism and replication, including host factors for entry and replication [12,13], the 52 
impact of mutations in the viral glycoproteins on cell entry [14], and cellular restriction factors 53 
acting against CHIKV and other alphaviruses [15,16]. Additionally, studies investigating 54 
immune responses to infection have demonstrated that CHIKV nsP2 counteracts host immunity  55 
by blocking nuclear translocation of STAT1 [17,18] and inducing a host transcriptional 56 
shutdown [19,20]. However, the relevance of these and potentially additional immunity-57 
subverting mechanisms in infected patients remains unclear. In vivo studies in mice, though 58 
recapitulating both innate and adaptive immune responses, require a type I interferon (IFN)-59 
deficient background, neglecting the impact of type I IFN-mediated antiviral responses [21]. 60 
However, type I IFN induced in and acting on nonhematopoietic cells appears to be essential 61 
for the control and early clearance of CHIKV in vivo [22-24]. Therefore, these systems do not 62 
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fully recapitulate the cellular environment of human primary cells and tissues that are targeted 63 
by CHIKV and MAYV in vivo. Primary human cells have been used sporadically, but only few 64 
studies properly characterized their unique properties [25-27]. Here, we perform an in depth-65 
characterization of primary human synovial fibroblasts as an ex vivo model of CHIKV and 66 
MAYV infection. Synovial fibroblasts have been described to be a key driver for rheumatoid 67 
arthritis by facilitating proinflammatory processes and stimulating the degradation of cartilage 68 
[28,29]. Here, we establish synovial fibroblasts as being fully susceptible and permissive to 69 
CHIKV and MAYV infection. Using bulk and single-cell approaches, we identified cell-70 
intrinsic immune responses that were most pronounced in abortively infected bystander cells, 71 
suggestive of effective viral antagonism of innate immunity in productively infected cells.  72 
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Material and Methods [1372 Words] 73 
Cells and Viruses  74 
Human osteosarcoma U2OS cells (a kind gift from T. Stradal, Hanover), human HEK293T 75 
cells (a kind gift from J. Bohne, Hanover), human foreskin fibroblast HFF-1 cells (ATCC 76 
SCRC-1041), human HL116 cells (a kind gift from Sandra Pellegrini, Institut Pasteur, France 77 
[30]), and hamster BHK-21 cells (ATCC CCL-10) were grown in Dulbecco’s modified Eagle’s 78 
medium - high glucose (DMEM, Sigma-Aldrich D5671) supplemented with 10 % heat-79 
inactivated fetal bovine serum (FBS, Sigma-Aldrich F7524), 2mM L-Glutamine (Gibco 80 
25030081), and 100 units/ml penicillin-streptomycin (Gibco 11548876). HL116 cell received 81 
1X HAT supplement (Gibco 21060017) in addition. Primary human fibroblasts were obtained 82 
from synovial biopsies from donors suffering from osteoarthritis (osteroarthrosis synovial 83 
fibroblasts, OASF) or a non-arthritic background (healthy donor synovial fibroblasts, HSF), 84 
purified, and cultured as described before [31]. The local ethic committee (Justus-Liebig-85 
University Giessen) approved the cooperative study (ethical vote IDs 66-08 and 74-05). All 86 
patients gave written informed consent. Mycoplasma testing was routinely performed and 87 
negative in all primary human cell cultures. After 2-4 passages of initial cultivation, cells were 88 
expanded and used for experiments in high glucose DMEM supplemented with 20 % FBS, 2 89 
mM L-Glutamine, 100 units/ml penicillin-streptomycin, 1 % non-essential amino acids (Gibco 90 
11140050), and 1 % sodium pyruvate (Gibco 11360070). The CHIKV LR2006-OPY 5’GFP 91 
and MAYV TRVL4675 5’GFP infectious clones expressing EGFP under the control of a 92 
subgenomic promotor (hereafter referred to as CHIKV and MAYV) have been described 93 
previously [32,33]. Virus was produced by in vitro-transcription of and subsequent 94 
electroporation of RNA into BHK-21 cells. Virus-containing supernatant was collected, 95 
passaged once on BHK-21 cells and viral titers were determined by titration on HEK293T cells. 96 
 97 
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Infection, Treatments, Transfections 98 
EGFP expression as surrogate for productive CHIKV or MAYV infection was quantified on a 99 
BD FACSCalibur, FACSLyric or Accuri C6. For neutralization assays, virus-containing 100 
supernatants were pre-incubated for one hour with anti-CHIKV E2 antibody C9 (Integral 101 
Molecular C9, Lot INT MAB-003) at 1 μg/ml or with recombinant MXRA8-Fc (a kind gift 102 
from M. Diamond) at 150 ng/ml. Recombinant  IFN-α2a (Roferon L03AB04, Roche) and IFN-103 
λ1 (Peprotech 300-02L) was used where indicated. Transfections were performed using 104 
Lipofectamine2000 (Thermo Fisher 11668019) for plasmid DNA (pcDNA6 empty vector) or 105 
5’triphosphate dsRNA (InvivoGen tlrl-3prna). 106 
 107 
Bulk RNA-Seq Analysis 108 
RNA was extracted using the Promega Maxwell 16 with LEV simplyRNA Tissue Kits 109 
(Promega AS1270). RNA quality was assessed using the Agilent Bioanalyzer and appropriate 110 
samples were used for NGS library preparation with the NEBNext Ultra II Directional RNA kit 111 
(NEB E7760) and sequenced with 50 bp paired-end reads and 30 mio reads per sample on the 112 
Illumina HiSeq 2500. Data was analyzed with CLC Genomics Workbench 12 (QIAGEN) by 113 
mapping the human reads onto the hg19 reference genome scaffold (GCA_000001405.28). 114 
Unmapped reads not matching the human genome were subsequently mapped onto the CHIKV 115 
genome LR2006_OPY (DQ443544.2). For HSF, infection and analysis were performed 116 
similarly, but RNA was extracted with the Direct-Zol RNA MiniPrep Kit (Zymo Research 117 
R2051), NGS libraries were prepared with the TruSeq stranded mRNA kit (Illumina 20020594) 118 
and sequencing was performed on the Illumina NextSeq500 with 65 mio reads per sample. 119 
Biological process enrichment was analyzed by Gene Ontology [34,35]. 120 
 121 
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Single-Cell RNA-Seq Analysis 122 
Infected cells were trypsinized, debris was removed by filtration, and the suspension was 123 
adjusted to a final amount of ~16,000 cells per lane to achieve the recovery of 10,000 cells per 124 
donor after partitioning into Gel-Beads in Emulsion (GEMs) according to the instructions for 125 
Chromium Next GEM Single Cell 3’ GEM, Library & Gel Bead Kit v3.1 provided by the 126 
manufacturer (10X Genomics PN-1000121). Polyadenylated mRNAs were tagged with unique 127 
16 bp 10X barcodes and the 10 bp Unique Molecular Identifiers (UMIs), reverse transcribed 128 
and resulting cDNAs were bulk amplified. After enzymatic fragmentation and size selection, 129 
resulting double-stranded cDNA amplicons optimized for library construction were subjected 130 
to adaptor ligation and sample index PCRs needed for Illumina bridge amplification and 131 
sequencing. Single-cell libraries were quantified using Qubit (Thermo Fisher) and quality-132 
controlled using the Bioanalyzer System (Agilent). Sequencing was performed on a HiSeq4000 133 
device (Illumina) aiming for 175 mln reads per library (read1: 26 nucleotides, read2: 64 134 
nucleotides). Data was analyzed using CellRanger v5.0 (10X Genomics) using human and 135 
CHIKV genome scaffolds as described above, and the R packages Seurat v4.0 [36] and 136 
DoRothEA v3.12 [37].  137 
 138 
Quantitative RT-PCR 139 
RNA was extracted using the Promega Maxwell 16 with the LEV simplyRNA tissue kit 140 
(Promega AS1270), the Roche MagNAPure with the Cellular Total RNA Large Volume kit 141 
(Roche 05467535001), or the DirectZol RNA Mini kit (Zymo R2051). cDNA was prepared 142 
using dNTPs (Thermo Fisher R0181), random hexamers (Jena Bioscience PM-301) and M-143 
MuLV reverse transcriptase (NEB M0253). For quantitative RT-PCR, specific Taqman probes 144 
and primers (Thermo Fisher 4331182) were used with TaqMan Universal PCR Master Mix 145 
(Applied Biosystems 4305719) or LightCycler© 480 Probes Master (Roche 04887301001). 146 
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PCRs were performed on the Applied Biosystems ABI 7500 Fast or the Roche LightCycler 480 147 
in technical triplicates. 148 
 149 
Flow Cytometry, Confocal and Live Cell Imaging 150 
For flow cytometric analysis of protein expression, OASF were fixed in 4 % PFA (Carl Roth 151 
4235.2), permeabilized in 0.1 % Triton-X (Invitrogen HFH10) and immunostained with 152 
antibodies against IFIT1 (Origene TA500948, clone OTI3G8), MX1/2 (Santa Cruz sc-47197), 153 
and IFITM3 (Abgent AP1153a) in combination with Alexa Fluor-647 conjugated antibodies 154 
against mouse- (Thermo Fisher A28181), rabbit- (Thermo Fisher A27040), or goat-IgG 155 
(Thermo Fisher A-21447). Flow was performed on a BD FACSCalibur or FACSLyric and 156 
analyzed with FlowJo v10. For immunofluorescence microscopy, OASF were seeded in 8-well 157 
μ-slides (ibidi 80826), fixed and permeabilized as described above, stained with antibodies 158 
against MXRA8 (biorbyt orb221523) with AlexaFluor647-conjugated secondary antibody 159 
(Thermo Fisher A28181), and counterstained with DAPI (Invitrogen D1306). For fluorescence 160 
microscopy and live cell imaging, cells were infected with CHIKV at an MOI of 10 and imaged 161 
with the Zeiss LSM800 Airyscan Confocal Microscope. Images were analyzed and merged 162 
using Zeiss ZEN Blue 3.0.  163 
 164 
Immunoblotting 165 
Cell lysates were separated on 10 % acrylamide gels by SDS-PAGE and protein  transferred to 166 
a 0.45 μm PVDF membrane (GE Healthcare 15259894) using the BioRad TransBlot Turbo 167 
system. Expression was detected using primary antibodies detecting MXRA8 (biorbyt 168 
orb221523), FHL1 (R&D Systems MAB5938), IFITM3 (Abgent AP1153a), MX2 (Santa Cruz 169 
sc-47197), ISG15 (Santa Cruz sc-166755), and α-Tubulin (Cell Signaling Technology 2144S) 170 
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and appropriate secondary IRDye antibodies. CHIKV proteins were detected using anti-CHIKV 171 
antiserum (IBT Bioservices Cat #01-0008 Lot #1703002). Fluorescence was detected and 172 
quantified using the LI-COR Odyssey Fc system. 173 
 174 
Measurement of IL-6 and Bioactive IFN 175 
Anti-IL-6 ELISA (BioLegend 430504) was performed according to manufacturer’s protocols. 176 
Briefly, plates were coated with capture antibodies and incubated with diluted supernatant from 177 
CHIKV- or mock-infected cell cultures . Detection antibody and substrate were added and the 178 
OD measured with the Tecan Sunrise microplate reader. Concentrations were then calculated 179 
the concentration according to a standard curve measured on the same plate. Bioactive type I 180 
IFN was quantified by incubating supernatant from CHIKV-infected cells on HL116 cells 181 
harboring a firefly luciferase gene under the control of an IFN-sensitive promotor. After six h, 182 
cells were lysed, incubated with luciferase substrate solution (Promega E1500), and luciferase 183 
activity was quantified with the BioTek Synergy HTX microplate reader. 184 
 185 
Data and Code Availability 186 
RNA-seq and single-cell RNA-seq datasets are available at the NCBI GEO database under the 187 
accession number GSE152782 and GSE176361, respectively. All generated code is available at 188 
https://github.com/GoffinetLab/CHIKV_scRNAseq-fibroblast. 189 
 190 
Data Presentation and Statistical Analysis 191 
If not stated otherwise, bars and symbols show the arithmetic mean of indicated amount of 192 
repetitions. Error bars indicate S.D. from at least three or S.E.M. from the indicated amount of 193 
individual experiments. Statistical analysis was performed using CLC Workbench for RNA-194 
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seq and GraphPad Prism 8.3.0 for all other analysis. Unpaired t-tests were applied with assumed 195 
equal standard deviation when comparing results obtained in the same cell line and Mann-196 
Whitney-U-tests when comparing between cell lines or between cell lines and primary cells.  197 
For treatment analysis, ratio paired t-tests were applied. For IC50 calculation, nonlinear fit 198 
curves with variable slopes were calculated. FDR correction was applied for RNA-seq analysis 199 
and Bonferroni correction for Gene Ontology analysis. P values <0.05 were considered 200 
significant (*), <0.01 very significant (**), <0.001 highly significant (***); < 0.0001 extremely 201 
significant, n.s. = not significant (≥0.05).   202 
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Results  203 
Osteoarthritic fibroblasts are susceptible and permissive to CHIKV and MAYV infection  204 
First, we examined the ability of primary human synovial fibroblasts to support the entire 205 
CHIKV and MAYV replication cycle. Therefore, we infected synovial fibroblasts obtained 206 
from osteoarthritic patients (OASF) and from patients with a non-arthritic background (HSF) 207 
with CHIKV strain LR2006-OPY or MAYV strain TRVL7546 expressing EGFP under the 208 
control of a second subgenomic promotor. 24 hours post-infection, the proportion of EGFP-209 
positive cells ranged between 4 and 24.5 % for CHIKV and between 8.5 and 39 % for MAYV 210 
and did not differ between fibroblast types (Fig. 1A). At the same time point, supernatants of 211 
both OASF and HSF displayed CHIKV titers of 1.6-8.8x105 infectious particles per ml and 212 
MAVV titers of 0.12-2.75x105 infection particles per ml, with significantly higher titers 213 
produced by OASF. At 48 hours post-infection, CHIKV titers produced by HSF did not further 214 
increase, whereas the titers produced by OASF reached up to 1.5x107 infectious particles per 215 
ml (Fig. 1B, left panel), suggesting slightly higher virus production and/or viral spread in OASF 216 
as compared to HSF. MAYV titers did not significantly increase in OASF or HSF at 48 hours 217 
post-infection (Fig. 1B, right panel). 218 
Susceptibility of cells to CHIKV infection is enhanced by the attachment factor MXRA8 219 
[12] and the cytosolic protein FHL-1 is essential for CHIKV genome replication [13]. We 220 
confirmed expression of these two cellular cofactors in OASF and HSF by immunoblotting 221 
and/or immunofluorescence (Fig. 1C). We assessed the functional relevance of the MXRA8 222 
attachment factor using a soluble MXRA8-Fc fusion protein, which blocks the binding site on 223 
the E1-E2 glycoprotein complex on the virus surface [12,38]. At a low MOI, MXRA8-Fc-224 
preincubated CHIKV was 50 % less infectious to synovial fibroblasts, and this inhibition was 225 
abolished when saturating amounts of infectious virus particles were used (Fig. 1D), indicating 226 
that endogenous MXRA8 contributes, at least partially, to CHIKV entry in OASF. 227 
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Subsequently, we investigated whether IL-1β-mediated activation of synovial 228 
fibroblasts, a hallmark of rheumatoid arthritis [39-41], modulates their susceptibility to CHIKV 229 
infection. Treatment with IL-1β, did not alter the percentage of EGFP-positive cells upon 230 
CHIKV challenge (Fig. 1E), while readily inducing IL-6 secretion (Fig. 1F). Conversely, 231 
CHIKV infection only very mildly, if at all, enhanced IL-1β-induced IL-6 secretion (Fig. 1F). 232 
These data suggest that CHIKV infection of synovial fibroblasts neither induces nor modulates 233 
IL-6 secretion, arguing against their activation. 234 
To determine the importance of IFN-mediated antiviral immunity in this primary cell 235 
system, we analyzed the secretion of type I IFN upon CHIKV infection, which reached higher 236 
levels than after prestimulation with IFN-α (Fig. 1G). Additionally, we monitored the CHIKV 237 
infection in the absence or presence of the JAK/STAT inhibitor Ruxolitinib. Using live-cell 238 
imaging, we documented the increase in EGFP-positive cells between ten and 48 hours post-239 
infection, which progressed faster in Ruxolitinib-treated cultures, with an onset of cytopathic 240 
effects observed after 24 hours in all infected cultures (Fig. 1H, Suppl. Mov. 1). Analysis of the 241 
EGFP intensity in each frame over time confirmed the higher expression of EGFP in 242 
Ruxolitinib-treated cultures (Fig. 1I, Suppl. Mov. 2). Overall, these experiments establish the 243 
susceptibility and permissiveness of synovial fibroblasts to CHIKV and MAYV infection and 244 
their expression of important cellular cofactors. Furthermore, we show an absence of 245 
interconnection between IL1-β activation and susceptibility to CHIKV infection, and restriction 246 
of infection through JAK/STAT-mediated innate immunity. 247 
 248 
CHIKV infection provokes a strong cell-intrinsic immune response in OASF  249 
Next, we performed RNA-seq analysis on OASF and HSF that had been infected with CHIKV 250 
in the presence or absence of the glycoprotein E2-binding, neutralizing antibody C9 [42], and 251 
on mock-infected cells. C9 pre-treatment resulted in potent inhibition of the infection by on 252 
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average 16-fold (Fig. 2A). Upon infection, expression of numerous IFN-stimulated genes 253 
(ISGs) was induced at the protein level in a C9 treatment-sensitive manner, including IFITM3, 254 
ISG15, and MX2. As expected, production of the viral E1-E2 and capsid proteins was 255 
detectable specifically in CHIKV-infected, but not in cells exposed to C9-pretreated virus (Fig. 256 
2B). Global transcriptional profiling by RNA-seq revealed 992 (OASF) and 1221 (HSF) 257 
upregulated genes as well as 99 (OASF) and 353 (HSF) downregulated genes in CHIKV-258 
infected cells 24 hours post-infection as compared to uninfected cells (Fig. 2C).  Uninfected 259 
cells and cells exposed to C9-treated virus shared a similar profile (data not shown). A high 260 
similarity of the gene expression profile of uninfected OASF and HSF (R2=0.9086) argues 261 
against a potential transcriptional predisposition that could have exerted a rheumatoid arthritis-262 
related gene expression profile or a broad proinflammatory activation (Fig. S1A). Uninfected 263 
OASF and HSF differed in genes involved in organ development and cellular regulatory 264 
processes, and not inflammatory or antiviral processes (Fig. S1B). Additionally, the 265 
transcriptional profile in infected OASF and HSF was very similar (R2=0.9085, Fig. S1C-D), 266 
with an equivalently strong upregulation of a set of prototypic inflammation and arthritis-267 
related genes which we defined for further analysis (R2=0.8202, Fig. 2D). Interestingly, the 268 
number of genes significantly up- and downregulated upon infection was 1.23-fold and 3.57-269 
fold higher in HSF compared to OASF, respectively, but 55.4% of upregulated genes from both 270 
groups overlapped (Fig. 2E).  Most of the prototypic antiviral and proinflammatory genes were 271 
highly upregulated in infected cells, demonstrating a broad and strong activation of antiviral 272 
immune responses in cells from four different donors with no statistically significant deviation 273 
in the magnitude of induction (Fig. 2F, left panel). Upregulation of IFNB and IFNL1, IFNL2, 274 
and IFNL3 expression was statistically significant but low in magnitude, with almost no IFNA 275 
mRNA detectable. Expression of arthritis-associated genes, including genes encoding immune 276 
cell chemoattractants (CXCL5, IL8, CD13, RANTES/CCL5), matrix-metalloproteases (MMP3, 277 
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-9, -14, ADAMTS5) and genes commonly expressed by fibroblasts in rheumatoid arthritis 278 
(FGF2, PDPN, NGF, FAP), was not grossly altered in CHIKV-infected cells. Exceptions were 279 
a strong CHIKV-induced upregulation of RANTES/CCL5 in both OASF and HSF and IL8 in 280 
HSF (Fig. 2F, right panel). mRNAs for all IFN receptors were detectable and stable with 281 
exception of IFNLR1, whose expression was upregulated upon CHIKV infection (Fig. S1E).  282 
Established host factors for CHIKV as well as fibroblast marker genes and cellular 283 
housekeeping genes were not quantitatively altered in their expression. Virtual absence of 284 
expression of monocyte/macrophage lineage-specific genes excluded the possibility of a 285 
contamination of the fibroblast culture with macrophages, which occasionally has been reported 286 
in early passages of ex vivo-cultured synovial fibroblasts [31] (Fig. S1E). Conclusively, OASF 287 
and HSF share similar basal and CHIKV infection-induced transcriptional profiles. Overall, 288 
CHIKV-infected OASF sense and react to productive CHIKV infection with the extensive 289 
upregulation of antiviral and proinflammatory ISGs. IFN expression itself was low at 24 hours 290 
post-infection, not excluding the possibility that it peaked transiently at earlier time points. 291 
 292 
High viral RNA levels in cells of infected cultures with an excess replication of the viral 293 
structural subgenome  294 
We noticed very little inter-donor variation regarding the distribution of identified viral reads 295 
along the viral genome. The 5´ region of the genome, encoding the non-structural CHIKV 296 
proteins, was replicated to a lower extent than the 3´, 26S subgenomic promoter-driven, 297 
structural protein-encoding genomic region. Interestingly, this differential abundance of 5´and 298 
3´ reads was also detected in cultures inoculated with C9-neutralized virus, suggesting infection 299 
in a small number of cells (Fig. 3A). Overall, the 26S subgenomic viral RNA was 5.3-fold more 300 
abundant than nonstructural subgenomes (Fig. 3B). 18-54 % and 17-44 % of the total reads in 301 
productively infected OASF and HSF, respectively, were attributed to the CHIKV genome (Fig. 302 
.CC-BY-ND 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 
The copyright holder for this preprintthis version posted June 11, 2021. ; https://doi.org/10.1101/2020.06.07.138610doi: bioRxiv preprint 
15 
 
3C, D). In summary, our analysis revealed efficient replication of the CHIKV genome in 303 
infected fibroblasts with an excess of structural protein-encoding subgenomic RNA.  304 
 305 
Exogenous IFN administration provokes higher immune responses and leads to improved 306 
protection from infection in primary fibroblasts than in commonly used cell lines 307 
CHIKV and MAYV infection rates in OASF did not increase after 24 hours post-infection (Fig. 308 
4A), and we suspected this to be the result of the strong immune activation and subsequent IFN 309 
signaling. The commonly used osteosarcoma cell line U2OS was more susceptible, while the 310 
immortalized fibroblast cells line HFF-1 displayed reduced susceptibility to alphaviral infection 311 
(Fig. 4A). OASF exhibited strong induction of IFIT1 and MX2 CHIKV infection, which 312 
exceeded those mounted by U2OS and HFF-1 cells at both 24 and 48 hours post-infection by 313 
15- to 150-fold. MAYV infection-provoked ISG responses in OASF were inferior to those 314 
induced by CHIKV, despite similar percentages of infected cells (Fig. 4B). Contrasting the cell 315 
system-specific magnitude of gene expression upon CHIKV infection, both OASF and cell lines 316 
shared similar responsiveness to 5’-triphosphate dsRNA (5-ppp-RNA) transfection, which 317 
exclusively stimulates the RNA sensor RIG-I [43], the main sensor of CHIKV RNA in infected 318 
cells [44], and plasmid DNA transfection (Fig. S2A).  319 
Next, we tested the cells´ ability to respond to exogenous type I and III IFNs, which 320 
play a crucial role in limiting virus infection and protecting the host [45-47]. We stimulated 321 
OASF individually with a range of IFN-α2 and -λ concentrations at 48 hours prior to infection. 322 
At all investigated concentrations, even the lowest dose, of IFN-α induced a potent upregulation 323 
of IFIT1 and MX2 (Fig. S2B), and almost completely inhibited CHIKV infection (Fig. 4C). In 324 
contrast, IFN-λ induced lower ISG expression levels (Fig. S2B), and inhibited infection less 325 
efficiently (Fig. 4C). Although less effective than in OASF, IFN-α restricted CHIKV infection 326 
both in U2OS and HFF-1 cells, while IFN-λ pre-treatment was more potent in U2OS cells than 327 
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in OASF, and ineffective in HFF-1 cells (Fig. 4C). These antiviral activities were largely 328 
consistent with the respective degree of ISG expression at the time point of infection (Fig. S2B).  329 
IFN-α and -λ induced expression of IFIT1 and MX2 was higher in U2OS cells than in HFF-1. 330 
We next investigated the sensitivity of CHIKV infection to IFN when applied four hours post-331 
infection. In this set-up, IFN-α still displayed a clear, though less potent antiviral activity when 332 
compared to the pre-treatment setting (Fig. 4D). In contrast, treatment of both immortalized cell 333 
lines with IFN-α post-infection was very ineffective (Fig. 4D). 334 
Interestingly, in all three cells systems, a preceding CHIKV infection did not antagonize 335 
IFN-mediated induction of ISGs, and led to expression levels of IFIT1 and MX2 exceeding 336 
those induced by IFN-α alone (Fig. S2C). Overall, the data suggest a stronger sensitivity of 337 
OASF to IFN-α-induced immunity compared to commonly used immortalized cell lines. Most 338 
interestingly, and in striking contrast to the immortalized cell lines, OASF were unique in their 339 
ability to transform a post-infection treatment of IFN-α into a relatively potent antiviral 340 
program. Collectively, these data uncover crucial differences between primary synovial 341 
fibroblasts and widely used immortalized cell lines regarding their cell-intrinsic innate response 342 
to infection and their sensitivity to exogenous IFNs.  343 
 344 
Virus-inclusive single-cell sequencing reveals a switch from induction to repression of 345 
immune responses depending on a threshold level of viral RNA in infected cells  346 
Finally, we asked how the cell-intrinsic defenses correlate with the amounts of viral RNA 347 
within cells of a given infected culture by analyzing infected OASF for their expression of 348 
antiviral proteins using flow cytometry. As expected, expression of IFIT1, IFITM3 and MX1/2 349 
was enhanced in OASF upon IFN-α treatment (Fig. 5A). Interestingly, these proteins were 350 
expressed at even higher levels in EGFP-negative cells of CHIKV-infected cultures, while the 351 
.CC-BY-ND 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 
The copyright holder for this preprintthis version posted June 11, 2021. ; https://doi.org/10.1101/2020.06.07.138610doi: bioRxiv preprint 
17 
 
productively infected, EGFP-positive cells displayed markedly reduced expression levels of 352 
these factors (Fig. 5A).  353 
Since absence of EGFP expression does not necessarily exclude the presence of viral, 354 
potentially abortive RNA, we performed virus-inclusive single-cell RNA-seq to establish 355 
potential correlations of the quantity of viral RNA and a specific cellular transcriptional profile. 356 
To this end, we analyzed infected OASF infected at escalating MOIs. No EGFP-positive cells 357 
were detectable at six hours post-infection by flow cytometry (Fig. 5B, left panel). In contrast, 358 
24 hours post-infection, the reporter was expressed in an MOI-dependent fashion, ranging from 359 
virtually 0% to 15% (Fig. 5B, left panel). IFIT1 and MX2 mRNA expression was largely 360 
proportional to EGFP expression (Fig, 5B, right panel).  361 
Single-cell (sc) RNA-seq of the very same cells showed very little inter-donor 362 
variability, and we merged data from both donors throughout the rest of the analysis (Fig. 5C). 363 
In order to identify potential correlations of viral RNA abundance and the cellular transcription 364 
profile, we compared the expression of CHIKV RNA to expression of 203 IFN signaling genes 365 
listed in the REACTOME database (identifier R-HSA-913531, Table 1). For each cell, the 366 
expression of this collection of genes was summarized using Seurat’s AddModuleScore 367 
function. Briefly, this summarizes the expression of a select group of genes by normalizing the 368 
aggregate expression to a randomly selected, non-overlapping subset of genes and scores each 369 
cell based on its expression of genes in this module, creating a module score (IFN Module 370 
Score, IMS). 24 hours post-infection, most identified CHIKV reads corresponded to the 3’ end 371 
of the genome, along with a minor number of reads mapping to the 3’ end of EGFP, which is 372 
expressed as a subgenomic RNA in infected cells (Fig. S3A). As expected for mock-infected 373 
cells, CHIKV reads were undetectable, and IFN signaling genes were expressed at basal levels, 374 
as calculated by the IMS. CHIKV RNA abundance per cell increased in an MOI-dependent 375 
manner, however susceptibility to infection was unequally distributed over individual cells, and 376 
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a subset of cells displayed a higher susceptibility than others, as reflected by a high percentage 377 
of reads attributed to the viral genome (Fig. S3B). Most interestingly, IFN signaling genes 378 
appeared to be induced predominantly in cells displaying low CHIKV gene expression. Vice 379 
versa, CHIKV RNA-positive cells maintained basal or reduced expression of IFN signaling 380 
related genes (Fig. 5D). Of note, six hours post-infection, CHIKV expression was low and 381 
antiviral responses as presented by the IMS was were largely absent at low MOIs,  while 382 
individual ISGs were induced at higher MOIs (Fig. S3C, D).  As opposed to the induction of 383 
IFN signaling genes, known CHIKV cofactors MXRA8, FHL1, and the fibroblast marker genes 384 
VIM and COL3A1 were broadly and stably expressed under all experimental conditions. 385 
Surprisingly, FURIN, encoding the cellular protease considered important for viral polyprotein 386 
cleavage, was detectable only in a minority of cells (Fig. S4). 387 
 388 
Correlating viral and cellular gene expression reveals a selective suppression of 389 
transcription factor and ISG expression 390 
In order to quantify expression of IFN signaling genes according to viral RNA abundance, we 391 
divided cells into three groups: cells without detectable viral RNA expression (bystander), cells 392 
displaying low amounts of viral RNA (low) and cells displaying high levels of viral RNA (high)  393 
(Fig. 6A). Mirroring our initial observations (Fig. 5), we detected a significantly lower IMS in 394 
high cells when compared to low or bystander cells of the identical culture (Fig. S5A). Six 395 
hours post-infection, differential expression of non-ISGs was very modest between bystander 396 
and viral RNA-positive cells, while it was clearly more pronounced 24 hours post-infection 397 
(Fig. S5B). In contrast, over 250 ISGs, including ISG15, IFIT1, MX2, IFITM3, MX1, and IFI6, 398 
were upregulated in viral RNA-positive cells as compared to bystander cells at both investigated 399 
time points. Individual comparisons of either low or high cells with bystander cells gave similar 400 
overall observations. However, at both investigated time points, no further upregulation of ISGs 401 
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was detected in the high cells as compared to low cells, but rather a significant downregulation 402 
of three ISGs at 24 hours post-infection and six ISGs at six hours post-infection. This suggests 403 
either a loss of cellular transcription activity or a lowered stability of cellular RNA in cells 404 
containing high loads of CHIKV RNA (Fig. S5B). 405 
To improve resolution, we calculated the average CHIKV and EGFP RNA expression 406 
and the average IMS in bins of 1000 cells for a total of 36 bins, sorted by their expression level 407 
of CHIKV RNA. At both time points, while the first 7-10 bins represented cells expressing no 408 
or virtually no CHIKV RNA, the following 18-21 bins represented cells displaying (according 409 
to the cut-off defined in Fig. 6A) low, but gradually increasing levels of CHIKV RNA, and 410 
largely undetectable EGFP RNA. We considered the latter cells to represent abortively infected 411 
cells due to their lack of subgenomic transcripts. The last eight bins displayed cells with overall 412 
high, starkly increasing levels of CHIKV RNA and with significant levels of EGFP mRNA. 413 
We hypothesize that these cells represent productively infected cells. Strikingly, in abortively 414 
infected cells, IMS values increased proportionally to the abundance of viral RNA per cell, 415 
whereas in productively infected cells, an inverse proportionality was observed (Fig. 6B). This 416 
dataset suggests that expression of IFN signaling genes is upregulated in cells harboring low-417 
to-intermediate levels of viral RNA, which, however, do not or have not yet progressed to a 418 
productive infection. In contrast, cells that exceed a certain threshold of viral RNA show a 419 
prevention or downregulation of the expression of IFN signaling genes. The analysis of 420 
expression of selected genes confirmed this observation. Expression of individual ISGs, 421 
including including ISG15, IFI6, MX1, OASL, IFITs, and IFITMs, and transcription factors, 422 
including STAT1 and IRF7, was low in mock-infected and bystander cells, and more 423 
pronounced in a representative low cells (six hours post-infection: bin 27-29, 24 hours post-424 
infection: bin 26-28) than in high cells (bins 34-36) (Fig. 6C). To identify further putative 425 
targets of viral antagonism, we correlated the expression of all 203 genes of the IMS to the viral 426 
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RNA expression in infected cells at 24 hours post-infection. We identified 13 genes displaying 427 
a significant positive correlation (r > 0.3) in the low CHIKV group, and a significant negative 428 
correlation (r < -0.3) in the high CHIKV group (IFITM3, IFIT3, OAS1, XAF1, GBP1, EIF4A1, 429 
EIF2AK2, STAT1, GBP3, UBC, PSMB8, UBA52). Strikingly, the only transcription factor 430 
present in both groups, STAT1, was also negatively correlated at six hours post-infection in the 431 
high viral RNA group. We additionally identified transcription factors JAK1 and IRF7 to switch 432 
from weak correlation in the low CHIKV group to a negative correlation in the high CHIKV 433 
group at 24 hours post-infection (Fig. 6D). We confirmed this finding using a transcription 434 
factor activity score analysis using the DoRotheEa database, which scores cells based on the 435 
activity of transcription factors inferred from the expression of the associated target genes in 436 
regulons, and found the regulon of STAT1 to be strongly induced in bystander and low CHIKV 437 
groups at high MOIs, yet highly susceptible to viral antagonism in the high CHIKV group. This 438 
was also true for multiple other transcription factors – IRFs and STATs as well as NFκB and c-439 
JUN - at higher MOIs, indicating a strong and sensitive induction that is counteracted in highly 440 
infected cells (Fig. 6E). Taken together, we demonstrate that the interaction between the virus 441 
and the host cell can be defined more precisely at single-cell resolution than by analyzing bulk 442 
data, and that the activation of innate immune responses can be well defined and correlated to 443 
the amount of viral RNA in the cell. Furthermore, viral antagonism may be masked by strong 444 
immune responses in cells infected at low levels, making it difficult to analyze using 445 
conventional RNA-seq.   446 
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Considering the CHIKV-induced arthritis, it is likely that cells of the synovium are directly 448 
implicated in the pathophysiology of CHIKV infection. Cells of the synovial tissue and synovial 449 
fluid contain CHIKV RNA and protein upon CHIKV infection in vivo in humans [9], 450 
experimentally infected macaques [48], and mice [49]. The main cell types composing the 451 
synovium are macrophages and fibroblasts. The latter have been identified to be susceptible to 452 
CHIKV infection ex vivo [12,50,51].  However, the corresponding basal innate immune state 453 
of primary synovial fibroblasts and their ability to exert IFN-mediated antiviral restriction is 454 
unknown. Here, we establish that the widely available OASF and less available HSF share 455 
susceptibility and permissiveness to CHIKV infection, and describe their basal and infection-456 
induced transcriptional programs. These findings are in line with reports on overall 457 
transcriptional similarity of the two cell types, except in some signaling pathways unrelated to 458 
immunity [52]. CHIKV infection provoked a striking cellular response that involves 459 
upregulation of multiple ISGs, many of them exerting antiviral activity. Although we did not 460 
define the PAMP(s) that trigger responses in synovial macrophages, infection by alphaviruses 461 
typically raises RIG-I-mediated responses through exposure of dsRNA intermediates and 462 
provokes mitochondrial DNA leakage that is sensed via cGAS/STING [44,53,54]. Indeed, 463 
experimental ligands of both sensors were highly reactive in OASF, as was IFN-α treatment. 464 
Surprisingly, also IFN-λ pre-treatment translated into an antiviral state, indicating that synovial 465 
fibroblasts may represent an exception to the notion of otherwise IFN-λ-nonresponsive 466 
fibroblasts [55]. Finally, CHIKV infection of synovial fibroblasts was sensitive to IFN-α 467 
applied after inoculation with virus. These findings appear to contrast with potent virus-468 
mediated antagonism of IFN in U2OS and HFF-1 cell lines, which has been suggested to 469 
involve counteraction of nuclear translocation of STAT1 [17,18]. CHIKV was unable to 470 
suppress ISG expression upon exogenous IFN treatment in any cell type, indicating that the 471 
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proposed antagonistic functions may not be strong enough to be detectable at the bulk level. 472 
Also, unaltered levels of expression of housekeeping genes and genes encoding fibroblast 473 
markers in primary synovial fibroblasts did not generate evidence for a general virus-mediated 474 
host transcriptional shut-off that has been reported for several cell lines [19,20]. Overall, 475 
synovial fibroblasts appear to respond differently to CHIKV infection as commonly used cell 476 
lines. The underlying reason for this difference is unknown, but may involve a different 477 
intracellular milieu that is hyper-responsive to CHIKV infection.  478 
 While our single-cell RNA-seq approach is dependent on 3’ end capture and does not 479 
allow for the discrimination between full-length and partial viral RNA, we found an excess of 480 
subgenomic RNA in infected cells. We found a similar the ratio of subgenomic to genomic 481 
RNA as measured in Sindbis virus infected cells [56]. The enhanced replication of the 482 
subgenomic RNA, which is mediated by the four cleaved nonstructural proteins forming a 483 
replication complex, ensures the rapid production of viral structural proteins and the formation 484 
of new virions [57,58]. While packaging of subgenomic RNA into virions has been described 485 
so far for one alphavirus, Aura virus [59], CHIKV holds a packaging signal in the nsP2 region 486 
of its genome, selecting only for full genomic RNA to be packaged into virions [60]. Therefore, 487 
we assume that the different abundance is based on de novo produced subgenomic RNA rather 488 
than on incoming viral RNA. 489 
Through correlating cellular gene expression with CHIKV RNA abundance in 490 
individual infected cells, it appears that a certain threshold of viral RNA is required to initiate 491 
viral RNA sensing and eventually trigger ISG expression. However, expression of most ISGs 492 
is negatively regulated in the presence of a high viral RNA burden per cell. This is fully 493 
consistent with the idea that productive infection involves the synthesis of viral antagonists that 494 
hamper the induction and/or evade the function of ISGs, resulting in efficient virus propagation. 495 
Along these lines, West Nile virus infection also results in lowered ISG expression levels in 496 
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cells harboring high viral RNA quantities [61]. In vivo, actively SARS-CoV-2 infected 497 
monocytes of COVID-19 patients expressed lower levels of ISGs than non-infected bystander 498 
[62]. Monocytes of Ebola-infected rhesus monkeys display similar dynamics, with an additional 499 
downregulation of STAT1 mRNA in infected cells [63]. On the contrary, cells that undergo 500 
abortive infection, or alternatively haven´t yet reached sufficient levels of virus replication, fail 501 
to mount a strong antiviral profile. HIV-1 infection of lymphoid resting T-cells, that provide a 502 
sub-optimal environment for HIV-1 infection, has been reported to result in the accumulation 503 
of abortive viral cDNA products that are sensed by IFI16 in an inflammasome/pyroptosis-504 
dependent manner [64]. HSV-1 infection results in antiviral signaling specifically in cells in 505 
which replication is stalled and that display relatively low levels of viral gene expression [65]. 506 
Owing to genetic recombination and low fidelity of the alphaviral RNA-dependent polymerase, 507 
defective alphaviral genomes (DVGs) and defective alphaviral particles arise during virus 508 
replication, but are themselves replication-incompetent [66,67]. Of note, our virus-inclusive 509 
sequencing approach does not have the power to distinguish between full-length viral genomes 510 
and defective or otherwise dead-end genomes. It will be interesting to test the contribution of 511 
the latter to triggering the strong cell-intrinsic innate recognition that we linked here to high 512 
intracellular viral RNA quantities in general. Strikingly, we find indication that the expression 513 
of some genes, such as proinflammatory transcription factors, may be actively targeted by 514 
CHIKV.  515 
Finally, the interplay of tissue-resident, synovial macrophages and fibroblasts likely 516 
additionally modulates CHIKV infection and cellular responses. Macrophages have been found 517 
to productively infect primary human macrophages [68] and to harbor persistent viral RNA in 518 
a nonhuman primate infection model [48]. Furthermore, human synovial fibroblasts secrete 519 
cytokines such as IL-6, IL1B, and RANTES stimulating monocyte migration upon CHIKV 520 
infection, and drive them towards an osteoclast-like phenotype [69,70]. Interestingly, we find 521 
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a similar phenotype in infected fibroblasts with upregulation and/or secretion of IL-6 and 522 
RANTES, but not matrix-metalloproteases (MMPs), as described before [69]. This suggests an 523 
indirect role of synovial fibroblasts in the induction of arthralgia upon infection, however, a 524 
paracrine stimulation of MMP expression by infiltrating immune cells can not be excluded in 525 
this model. Bystander cells, defined here as cells from infected cultures without detectable viral 526 
RNA, may be strongly impacted through paracrine signaling by infected cells [71]. 527 
Interestingly, at 24 hours post-infection we do not observe an extensive activation of bystander 528 
cells in cultures infected with a low MOI, despite an established infection and a number of 529 
IFNB-expressing cells. On the other hand, at six hours post-infection in cultures infected with 530 
an MOI 10, a condition in which we expect that almost all cells have made contact with virus 531 
particles, we observe a strong activation of the RNA-negative cells. This indicates that either a 532 
rapid release of cytokines and interferons only in highly infected cultures, or an interferon-533 
independent sensing of viral PAMPs leads to abortive infection.  534 
It is tempting to speculate that the synovial fibroblast-specific hyperreactivity is linked 535 
to the long-term arthralgia observed in vivo in chronic CHIKV patients, and that 536 
pharmacological interference with hyperinflammation represents a feasible intervention 537 
approach towards the alleviation of long-term arthralgia. In rheumatoid arthritis, hyperactivated 538 
synovial fibroblasts invade the joint matrix, destroying/disrupting the cartilage and causing 539 
long-term inflammation [28,72]. This and the subsequent attraction of immune cells, including 540 
monocyte-derived macrophages to the damaged sites, may represent important events in the 541 
progression to long-term morbidity [73]. Indeed, data obtained in recent clinical studies 542 
suggests that treatment of chikungunya-induced arthritis with the immunosuppressant 543 
methotrexate may be a beneficial strategy [74,75]. The data presented here does not fully 544 
support the hypothesis that infected synovial fibroblasts display a phenotype similar to 545 
fibroblasts in rheumatoid arthritis, but key features such as the IL-1β-mediated IL-6 release, the 546 
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aggressive proinflammatory gene expression in productively infected cells, and the strong 547 
expression of important cofactors make them likely to contribute to viral replication and disease 548 
progression in vivo.  549 
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Figure Legends [1150 Words] 762 
Figure 1. Osteoarthritis fibroblasts are susceptible and permissive to CHIKV infection. 763 
(A) OASF or HSF were infected with 5’EGFP-CHIKV or -MAYV (MOI 10). 24 hours post-764 
infection, the percentage of EGFP-positive cells was quantified by flow cytometry (n = 3-12). 765 
(B) Supernatants of CHIKV- and MAYV-infected OASF or HSF were collected at 24 and 48 766 
hours post-infection, and titers were determined by analyzing EGFP expression at 24 hours 767 
post-infection of HEK293T cells. For background controls (post-wash), samples were taken 768 
after one hour of virus inoculation and subsequent washing (n = 3).  769 
(C) Uninfected OASF and HSF were analyzed for MXRA8 and FHL1 expression by 770 
immunoblotting (n = 4-6) and for MXRA8 expression by immunofluorescence. Scale bar = 50 771 
μm (n = 3, representative images shown).  772 
(D) OASF were infected with 5’EGFP-CHIKV at the indicated MOIs upon treatment of the 773 
virus with MXRA8-Fc recombinant protein or mock treatment. At 24 hours post-infection, cells 774 
were analyzed for EGFP expression (n = 4).  775 
(E) OASF were stimulated with IL-1β at 10 ng/ml for 16 hours and subsequently infected with 776 
CHIKV (MOI 10) in the presence of IL-1β. Mock-stimulated OASF were infected as a control. 777 
At 24 and 48 hours post-infection, cells were analyzed for EGFP expression and (F) supernatant 778 
was collected and analyzed for IL-6 secretion by ELISA (n = 3).  779 
(G) OASF were infected with 5’EGFP-CHIKV or treated with 200 IU/ml IFN-α. 24 h later, 780 
supernatants of the infected cells were incubated on HL116 reporter cells to quantify secreted 781 
bioactive type I IFN (n = 4).   782 
(H) OASF were infected with 5’EGFP-CHIKV (MOI 10) in the presence or absence of 1 or 10 783 
μM Ruxolitinib or mock-infected. Infection was recorded by live-cell imaging and 784 
representative images for untreated and 10 μM Ruxolitinib-treated cells are shown. Scale bar = 785 
100 μm. 786 
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(I) Infected cells recorded by live-cell imaging in G were analyzed for EGFP intensity using 787 
ImageJ (n = 3).   788 
 789 
Figure 2. Productive CHIKV infection provokes a strong cell-intrinsic immune response 790 
in OASF and HSF.  791 
(A) OASF were infected with 5’EGFP-CHIKV at an MOI of 10 in the presence or absence of 792 
the anti-E2 antibody C9 and the percentage of EGFP-positive cells was measured by flow 793 
cytometry (OASF: squares, HSF: diamonds. The infected samples are marked with their 794 
respective donor number). 795 
(B) Selected proteins of cells infected in A were analyzed by immunoblotting. 796 
(C-F) RNA from cells infected in A was extracted and subjected to RNA-seq (n = 4).  797 
(C) Analysis of up- and downregulated genes in CHIKV-infected samples compared to mock. 798 
Dotted lines indicate cutoff for <1.5 fold regulation and a p-value of >0.05.  799 
(D) Visualization of the fold change induction of indicated genes in CHIKV-infected OASF 800 
and HSF. Average fold change (log2) values for infected OASF are plotted on the x-axis, with 801 
corresponding values from infected HSF plotted on the y-axis. R2 value and regression line for 802 
the comparison are inset, dot sizes indicate significance. 803 
(E) Overlap of significantly (FDR-p <0.05) up- and downregulated genes in infected OASF 804 
and HSF. Numbers of genes up- or downregulated in either OASF or HSF only, or in both cell-805 
types, are indicated.  806 
(F) Heatmaps of selected gene expression profiles related to innate immune responses (left) or 807 
to secreted proinflammatory mediators and arthritis-connected genes (right) in uninfected or 808 
CHIKV-infected cells.   809 
 810 
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Figure 3. The CHIKV genome is replicated to a high degree with a strong bias towards 811 
the structural subgenome in infected OASF. 812 
(A) NGS reads attributed to each individual position in the CHIKV genome plotted for cells 813 
infected with CHIKV in the presence or absence of neutralizing antibody (nAb). SGP: 814 
subgenomic promotor.  815 
(B) Normalized amount of reads attributed to the structural and nonstructural part of the CHIKV 816 
genome in CHIKV-infected OASF and HSF.  817 
(C) Number of NGS reads attributed to the human or CHIKV reference genome in CHIKV or 818 
neutralizing antibody-treated CHIKV infected OASF or (D) HSF. 819 
 820 
Figure 4. OASF react to CHIKV infection more strongly than commonly used cell lines 821 
and can potently inhibit viral infection after IFN treatment.  822 
(A) OASF and HFF-1 cells were infected with 5’EGFP-CHIKV at an MOI of 10, U2OS cells 823 
were infected at an MOI of 0.5. EGFP-positive cells were quantified at 24 and 48 hours post-824 
infection by flow cytometry (n = 3-6).  825 
(B) Cells infected in (A) were analyzed for expression of IFIT1 and MX2 mRNA at 24 and 48 826 
hours post-infection by quantitative RT-PCR (n = 3-6).  827 
(C) Cells were treated with IFN-α or -λ for 48 h before infection with 5’EGFP-CHIKV (OASF 828 
and HFF-1: MOI 10; U2OS: MOI 0.5) in the continuous presence of IFN. Inset numbers 829 
indicate IC50 values for each timepoint. 830 
(D) Cells were infected with 5’-EGFP CHIKV (OASF and HFF-1: MOI 10; U2OS: MOI 0.5) 831 
and IFN-α was added four hours post-infection. 24 and 48 hours post-infection, EGFP-positive 832 
cells were quantified by flow cytometry. Inset numbers indicate IC50 values for each timepoint.  833 
UT: untreated, IU: international units (n = 3 for all experiments) 834 
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Figure 5. Reduced induction of antiviral protein and gene expression in productively 836 
infected cells. 837 
(A) OASF were infected with 5’EGFP-CHIKV (MOI 10) or treated with 100 IU/ml IFN-α and 838 
immunostained for IFIT1, IFITM3, and MX1/2 24 hours post-infection. Numbers in the dot 839 
plots indicate mean fluorescence intensities (MFI) of one representative experiment, and the 840 
bar diagram shows quantification of three individual experiments.  841 
(B) OASF were infected with 5’EGFP-CHIKV at indicated MOIs. Six and 24 hours post-842 
infection, EGFP-positive cells were quantified by flow cytometry (left panel), and cells were 843 
analyzed for expression of IFIT1 and MX2 mRNA (right panel, n = 6).  844 
(C) Using OASF infected with 5’EGFP-CHIKV, single-cell RNA-sequencing was conducted 845 
and UMAP visualizations for sample overlapping after integration are shown.  846 
(D) UMAP projections from infected OASF (24 hours post-infection) indicate the abundance 847 
of CHIKV 3’ end reads, EGFP 3’ end reads, and IFN signaling gene expression as calculated 848 
by IMS.   849 
 850 
Figure 6. Transcriptomic differences between uninfected, bystander, and lowly or highly 851 
CHIKV infected OASF. 852 
(A) Visualization of the viral RNA content of infected OASF from Fig. 5 at six and 24 hours 853 
post-infection. Line indicates the cutoff dividing cells displaying low and high content of viral 854 
RNA. Bystander cells were defined as cells with no detectable viral RNA.  855 
(B) Infected OASF were sorted into digital bins of 1000 cells displaying a gradual increase of 856 
the amount of viral reads per cell. Viral reads and the IMS at six and 24 hours post-infection 857 
are plotted.  Colored bins indicate selected representative cells for low and high content of viral 858 
RNA. 859 
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(C) Expression of selected genes within mock, bystander, representative low cell bins  (bin 26-860 
29) and high cell bins (bin 34-36) defined in A and B at six and 24 hours post-infection. Arrows 861 
indicate a statistically significant (p<0.05, fold change >1.5) up- or downregulation (depending 862 
on the arrow direction) in low or high CHIKV bins versus bystander (inside the boxes) or in 863 
high CHIKV bins versus low (next to the boxes).  864 
(D) Correlation of CHIKV RNA expression with expression of IFN signaling genes in high and 865 
low CHIKV RNA groups calculated by non-parametric Spearman’s test. Transcription factors 866 
are plotted in white, with selected genes in red. 867 
(E) Activity of transcription factor regulons within groups defined in A at six and 24 hours 868 
post-infection. Arrows indicate a significant up- or downregulation between bystander and low 869 
or high CHIKV groups (inside the boxes) or between low and high CHIKV groups (next to the 870 
boxes).  871 
 872 
Supplemental Figure 1. HSF and OASF share a similar basal and CHIKV infection-873 
induced transcriptome.   874 
(A) Visualization of global transcriptional differences between OASF and HSF under regular 875 
culturing conditions. Average RPKM (log10) values for all detected transcripts from OASF are 876 
plotted on the x-axis, with corresponding values from HSF plotted on the y-axis. R2 value and 877 
regression line for comparison are inset.  878 
(B) Gene ontology analysis of differentially expressed genes in OASF compared to HSF.  879 
(C) Visualization of global transcriptomic differences between CHIKV-infected OASF and 880 
HSF as described in A.  881 
(D) Gene ontology analysis of the top significantly upregulated pathways in OASF, HSF, and 882 
shared by both in response to CHIKV infection.  883 
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(E) Heatmaps of selected gene expression profiles of IFN receptors, CHIKV host cofactors, 884 
and celltype markers. 885 
 886 
Supplemental Figure 2. OASF, U2OS, and HFF-1 respond with a differently strong 887 
upregulation of ISGs to IFN treatment and CHIKV infection despite similar 888 
responsiveness to PAMPs. 889 
(A) Indicated cell cultures were transfected with 5’-triphosphate dsRNA (5-ppp-RNA, left) or 890 
plasmid DNA (right) and analyzed for the expression of IFIT1 (left) and MX2 (right) mRNA at 891 
24 and 48 hours post transfection (n = 3-4). 892 
(B) OASF, U2OS, and HFF-1 cells were analyzed for the expression of IFIT1 and MX2 by 893 
quantitative RT-PCR after 48 h treatment with the indicated amounts of IFN-α or –λ.  894 
(C) OASF, U2OS, and HFF-1 cells were infected with 5’-EGFP CHIKV (MOI 10) and 895 
indicated amounts of IFN-α were added four hours post-infection. At 24 and 48 hours post-896 
infection, OASF were analyzed for the expression of IFIT1 and MX2 mRNA by quantitative 897 
RT-PCR (n = 3).  898 
 899 
Supplemental Figure 3. Cofactor expression in OASF and mild IFN signaling gene 900 
expression in infected OASF.  901 
(A) NGS reads after 3’ mRNA capture attributed to each individual position in the CHIKV 902 
genome plotted for cells infected with CHIKV at six and 24 hours post-infection. SGP = 903 
subgenomic promotor 904 
(B) Infected OASF were sorted into 100 digital bins per infection condition (MOI) displaying 905 
a gradual increase of the amount of viral reads per cell. Average proportion of reads per cell 906 
attributed to CHIKV at six and 24 hours post infection are plotted. 907 
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(C) UMAP projections were generated for the six hours post infection time point. Shown is the 908 
abundance of CHIKV 3’ end reads and of IFN signaling genes according to IMS.   909 
(D) Expression of IFN-stimulated genes in infected OASF at six and 24 hours post-infection. 910 
UMAP visualization shows infected cells split by the MOI and mock-infected cells separately. 911 
 912 
Supplemental Figure 4. IFN-stimulated gene expression in infected OASF.  913 
Expression of alphavirus infection cofactors and fibroblast marker genes in infected OASF. 914 
UMAP visualization shows infected cells split by the MOI and mock-infected cells separately. 915 
 916 
Supplemental Figure 5. IFN signaling gene expression and transcriptional changes 917 
between infected subgroups of cells. 918 
(A) IMS in uninfected, bystander, CHIKV low and CHIKV high OASF at six and 24 hours 919 
post-infection. Statistical significance between groups was tested using a non-parametric KS-920 
test.  921 
(B) Analysis of significantly up- and downregulated genes between indicated cell subgroups at 922 
six and 24 hours post-infection.  923 
 924 
Supplemental Movie 1. CHIKV spreads in OASF culture.  925 
OASF 5’-EGFP-CHIKV-infected OASF were monitored for EGFP expression by live-cell 926 
imaging. Scale bar = 100 μm. 927 
 928 
Supplemental Movie 2. Ruxolitinib treatment boosts CHIKV spread. 929 
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OASF were pretreated with 10 μM Ruxolitinib for 16 hours, infected with 5’-EGFP-CHIKV in 930 
the presence of Ruxolitinib and monitored for EGFP expression by live-cell imaging. Scale bar 931 
= 100 μm. 932 
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Pott et al., Table 1
AAAS HLA-DRB3 ISG15 PLCG1 TRIM68
ABCE1 HLA-DRB4 ISG20 PML TRIM8
ADAR HLA-DRB5 JAK1 POM121 TYK2
ARIH1 HLA-E JAK2 POM121C UBA52
B2M HLA-F KPNA1 PPM1B UBA7
BST2 HLA-G KPNA2 PRKCD UBB
CAMK2A HLA-H KPNA3 PSMB8 UBC
CAMK2B ICAM1 KPNA4 PTAFR UBE2E1
CAMK2D IFI27 KPNA5 PTPN1 UBE2L6
CAMK2G IFI30 KPNA7 PTPN11 UBE2N
CD44 IFI35 KPNB1 PTPN2 USP18
CIITA IFI6 MAPK3 PTPN6 USP41
DDX58 IFIT1 MID1 RAE1 VCAM1
EGR1 IFIT2 MT2A RANBP2 XAF1
EIF2AK2 IFIT3 MX1 RNASEL
EIF4A1 IFITM1 MX2 RPS27A
EIF4A2 IFITM2 NCAM1 RSAD2
EIF4A3 IFITM3 NDC1 SAMHD1
EIF4E IFNA1 NEDD4 SEC13
EIF4E2 IFNA10 NUP107 SEH1L
EIF4E3 IFNA13 NUP133 SOCS1
EIF4G1 IFNA14 NUP153 SOCS3
EIF4G2 IFNA16 NUP155 SP100
EIF4G3 IFNA17 NUP160 STAT1
FCGR1A IFNA2 NUP188 STAT2
FCGR1B IFNA21 NUP205 SUMO1
FLNA IFNA4 NUP210 TPR
FLNB IFNA5 NUP214 TRIM10
GBP1 IFNA6 NUP35 TRIM14
GBP2 IFNA7 NUP37 TRIM17
GBP3 IFNA8 NUP42 TRIM2
GBP4 IFNAR1 NUP43 TRIM21
GBP5 IFNAR2 NUP50 TRIM22
GBP6 IFNB1 NUP54 TRIM25
GBP7 IFNG NUP58 TRIM26
HERC5 IFNGR1 NUP62 TRIM29
HLA-A IFNGR2 NUP85 TRIM3
HLA-B IP6K2 NUP88 TRIM31
HLA-C IRF1 NUP93 TRIM34
HLA-DPA1 IRF2 NUP98 TRIM35
HLA-DPB1 IRF3 OAS1 TRIM38
HLA-DQA1 IRF4 OAS2 TRIM45
HLA-DQA2 IRF5 OAS3 TRIM46
HLA-DQB1 IRF6 OASL TRIM48
HLA-DQB2 IRF7 PDE12 TRIM5
HLA-DRA IRF8 PIAS1 TRIM6
HLA-DRB1 IRF9 PIN1 TRIM62
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